Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2Tumor-Agnostic 1Thoracic 1Plasma cell 1Genitourinary 1

Conditions

Cognitive Dysfunction 1Breast Neoplasms 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Trastuzumab 379Paclitaxel 369Cyclophosphamide 338Docetaxel 314Capecitabine 198Doxorubicin 196Letrozole 184Tamoxifen 154Carboplatin 153Fulvestrant 136Bevacizumab 129Anastrozole 120exemestane 119Lapatinib 117Epirubicin 116Gemcitabine 112Radiotherapy 107palbociclib 94Exercise 87Fluorouracil 83Vinorelbine 82Surveys and Questionnaires 81pertuzumab 77Albumin-Bound Paclitaxel 76Filgrastim 71130-nm albumin-bound paclitaxel 64pembrolizumab 63Everolimus 59Cisplatin 59eribulin 58

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Tai Ji × Breast × Clear all
NCT04716920 2025-04-29

Tai Chi for Relieving Aromatase Inhibitor-Induced Arthralgia in Patients With Stage I-III Breast Cancer, the TaiChi4Joint Trial

Thomas Jefferson University

Phase NA Completed
39 enrolled
Breast

Anatomic Stage I Breast Cancer AJCC v8

NCT03196037 2019-03-07

Feasibility of an 8-week Tai Chi Chuan Intervention for Breast Cancer Survivors

UNC Lineberger Comprehensive Cancer Center

Phase NA Completed
4 enrolled
Breast

Breast Neoplasms, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡